Upgrade to SI Premium - Free Trial

Evolent Health (EVH) PT Lowered to $6 at Truist Securities

August 12, 2026 5:09 AM
Truist Securities analyst Jailendra Singh lowered the price target on Evolent Health (NYSE: EVH) to $6.00 (from $7.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change